-transparent.png){kind=logo}
The fetal regressor Müllerian inhibiting substance (MIS), in concentrations as low as picomolar, inhibited the growth of A-431 cells and the autophosphorylation of its epidermal growth factor (EGF) receptor. The inhibition of membrane phosphorylation was due neither to the reduction of the total number of EGF receptor binding sites, nor to stimulation of intrinsic phosphates, but rather to inhibition of tyrosine kinase activity. MIS control of EGF receptor autophosphorylation by tyrosine kinase may be one mechanism by which Müllerian duct regression in the embryo and the inhibition of A-431 proliferation is initiated. In addition, MIS as an inhibitor of phosphorylation may furnish a tool to probe the role of membrane phosphorylation in growth control.
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
September 2013,
FEBS letters,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
November 1991,
Metabolism: clinical and experimental,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
June 1995,
The Journal of pathology,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
October 1993,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
October 1988,
The EMBO journal,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
December 1993,
Endocrinology,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
January 2003,
FEBS letters,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
May 1999,
Journal of immunological methods,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
January 2002,
BJU international,
J P Coughlin, and
P K Donahoe, and
G P Budzik, and
D T MacLaughlin
June 2007,
Proceedings of the National Academy of Sciences of the United States of America,
